Company / SG&A Expense
UTAH MEDICAL PRODUCTS INC SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$11.0M
FY2025
5-year range
$9.6M / $11.0M
FY2021-FY2025
Trend
+5.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has increased for 7 consecutive years, from $5M in FY2018 to $11M in FY2025.
Based on SEC 10-K filings.
$11M in FY2025 with a 5-year CAGR of +15.1%.
Increased from $10M to $11M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +4.0%
- 5-Year CAGR
- +15.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- UTAH MEDICAL PRODUCTS INC's sg&a expense has grown for 7 consecutive years.
- 5-year CAGR of +15.1%, indicating consistent growth.
- In FY2025, sg&a expense increased 5.9% year-over-year.
- Lowest sg&a expense in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.0M | +5.9% |
| FY2024 | $10.4M | +3.1% |
| FY2023 | $10.1M | +3.0% |
| FY2022 | $9.8M | +1.9% |
| FY2021 | $9.6M | +76.5% |
| FY2020 | $5.4M | +1.0% |
| FY2019 | $5.4M | +0.7% |
| FY2018 | $5.4M | -8.4% |
| FY2017 | $5.8M | -4.3% |
| FY2016 | $6.1M | -0.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026